MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What Does Stopping GLP-1 Treatment Really Mean for Your Heart

4 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does a CEO's Stock Purchase Really Mean for Investors

4 months ago

What Does High Short Interest Really Mean for a Stock

5 months ago

Is the GLP-1 Price War Escalating, and What Does it Mean for Eli Lilly

5 months ago

What Does the Glaukos CFO's Stock Sale Really Mean for Investors

4 months ago

Fractyl Health Helps Maintain Weight After Stopping Popular Obesity Drugs, Stock Soars

Fractyl Health (GUTS) stock soared after one-year REMAIN-1 study data showed a single Revita DMR treatment helped patients maintain more GLP-1-induced weight loss vs sham.

BPOP

Stock News•1 months ago

Weight-Loss Drugs Are Reshaping the Body. New Yorkers Are Rethinking What Comes Next

GLP-1 weight-loss drugs are reshaping patient bodies, prompting New York aesthetic clinics to see a shift in demand for post-weight-loss body contouring procedures.

Stock News•1 months ago

Use of GLP-1 drugs early in pregnancy should not cause alarm

GLP-1 drug use early in first trimester poses no alarm, per a large new data analysis. The finding could ease concerns for women with diabetes or obesity.

GLP

Stock News•2 months ago

Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke

A Novo Nordisk observational study (POSEIDON) found that 2 in 5 patients with cardiovascular disease exhibit cardiovascular inflammation. This condition significantly elevates the risk of heart attack...

NVO